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Abstract The incentive for developingmicrobial cell factories
for production of fuels and chemicals comes from the ability of
microbes to deliver these valuable compounds at a reduced
cost and with a smaller environmental impact compared to
the analogous chemical synthesis. Another crucial advantage
of microbes is their great biological diversity, which offers a
much larger Bcatalog^ of molecules than the one obtainable by
chemical synthesis. Adaptation to different environments is
one of the important drives behind microbial diversity. We
argue that the Red Sea, which is a rather unique marine niche,
represents a remarkable source of biodiversity that can be
geared towards economical and sustainable bioproduction pro-
cesses in the local area and can be competitive in the interna-
tional bio-based economy. Recent bioprospecting studies, con-
ducted by the King Abdullah University of Science and
Technology, have established important leads on the Red Sea
biological potential, with newly isolated strains of Bacilli and
Cyanobacteria. We argue that these two groups of local organ-
isms are currently most promising in terms of developing cell
factories, due to their ability to operate in saline conditions,
thus reducing the cost of desalination and sterilization. The
ability of Cyanobacteria to perform photosynthesis can be fully
exploited in this particular environment with one of the highest
levels of irradiation on the planet. We highlight the importance
of new experimental and in silico methodologies needed to
overcome the hurdles of developing efficient cell factories
from the Red Sea isolates.
Keywords Metabolic engineering . Synthetic biology .
Industrial biotechnology . Cell factories .Metagenomics
Introduction
Humans have exploited microorganism for production of
fermented food products for thousands of years, but with the
identification and isolation of microbial species responsible
for specific fermentation process, e.g., production of beer
and wine, the path was opened for wider use of microorgan-
isms for production of chemicals. This led Chaim Weismann
to develop a fermentation process for production of acetone-
butanol-ethanol duringWorldWar 1 (Weizmann 1915), a pro-
cess that was used for about 50 years to produce acetone and is
today being revived for production of 1-butanol that can be
used as a chemical building block and as a biofuel. A few
years later, the filamentous fungus Aspergillus nigerwas iden-
tified to have the ability to produce citric acid at conditions of
very low pH, and this led to the development of the first large-
scale aerobic fermentation process for production of citric acid
(Currie 1917). Today this process is still in use for production
of citric acid that is used in soft drinks and for food preserva-
tion (Papagianni 2007). Another landmark in industrial fer-
mentation was the development of a large-scale process for
production of penicillin, which was discovered by Alexander
Fleming in 1929 (Fleming 1944). It took several years from
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the original discovery to development of an industrial process,
primarily due to belief that penicillin could be synthesized
chemically. However, during World War 2 the War
Production Board in the USA decided to endorse the fermen-
tation route, which resulted in production of the first large-
scale batches of penicillin in 1943. The development of an
industrial scale fermentation process for production of peni-
cillin was challenging. Knowledge from citric acid production
at large scale could be used, but as penicillin production is not
at low pH it was necessary to develop the technology for
sterilization of production fermenters and ensure provision
of large amounts of sterile air required for the aerobic produc-
tion process. Following World War 2, the same technology
used for production of penicillin could rapidly be applied for
production of many other antibiotics that were discovered in
the 1950s and 1960s. Development of the abovementioned
three production processes each represent technological
breakthroughs that today supports a billion USD industry
where microorganisms are used for production of pharmaceu-
ticals, enzymes, biofuels, chemicals, food, and feed ingredi-
ents, and we will later provide a brief review of products
currently produced by microbial fermentation. Even though
the production of recombinant proteins used as pharmaceuti-
cals represent a major contribution of this market value, with
an estimated value of about USD 100 billion (Nielsen 2013),
the production of fuels and chemicals is increasing rapidly
with a market value of USD 32 billion in 2010 and estimated
to be above USD 75 billion in 2017.
There are three key drivers for the fuel and chemical indus-
try to shift towards bio-based production: (1) The opportunity
to produce newmolecules that have improved properties com-
pared with currently available chemicals. A good example of
this, as will be discussed later, is lactic acid to be used for
production of polylactic acid (PLA). PLA has a number of
properties as a polymer that makes it well suited for wide
applications, including fabrics to be used in sports clothes
and biodegradable packing materials (Lunt 1998). (2) The
opportunity to produce chemicals cheaper than through tradi-
tional routes. Even though the chemical industry has been
extremely successful in producing a wide range of chemicals
from oil, some chemicals are hard to produce at low costs
through cracking and catalysis. A good example of this is
1,3 propanediol, as also will be discussed below, that can be
used to produce Sorona®, a valuable polymer that is used in
fabrics and carpets (Ritter 2003). (3) The opportunity to pro-
duce chemicals with a reduced environmental footprint. Many
new biotech processes have a lower environmental footprint
than traditional chemical synthesis, not only in terms of car-
bon dioxide emission but also in terms of water and energy
usage. Furthermore, through the use of plant materials, either
crops or biomass, there is a sustainable availability of the
feedstock used, which makes the production independent of
oil availability (Shahzad et al. 2013).
There are, however, several challenges for developing a
bio-based process for chemical production: (1) Bio-based pro-
duction requires development of a cell factory that can effi-
ciently convert the feedstock, typically sugar, to the product of
interest. This requires extensive engineering of the cellular
metabolism, which is challenging due to extensive regulation
of metabolism in living cells. (2) It is important to have con-
tinuous access to a feedstock that can be used for production
for microbial fermentation. (3) Development of a bioprocess
that is matched with the cell factory and that can ensure low
cost production of the chemical at large scale. Here we will
briefly review current bio-based production of fuels and
chemicals and we will thereafter discuss the opportunities
for developing bio-based production of fuels and chemicals
in the Middle East. Our discussion will follow the concept
illustrated in Fig. 1.
The current bioindustry
As mentioned above, the market for renewable chemicals is
growing rapidly and a list of some of the major products is
provided in Table 1. One observation from this list is that
relatively few cell factories are used for production of a quite
wide range of chemical compounds, and these widely used
cell factories are typically referred to as platform cell factories
(Nielsen and Keasling 2016). The main reason for this is the
challenge of developing an efficient cell factory, and indus-
tries therefore prefer to use cell factories for which there is a
Fig. 1 The Red Sea is a rich and untapped ecosystem for bio-based
production of high-value chemicals. Microalgae and/or cyanobacteria
that can grow in the saline and high sun-intensive environment can be
used for generation of biomass to be used for microbial fermentation.
These can be grown in farms at the shore right next to biorefineries. It
may be possible to extract some high-value chemicals directly from the
microalgae, with the remainder of the biomass being used for microbial
fermentation. In order to reduce cost, the biomass should not be extracted
from isolated saline water, but it should be hydrolyzed in suspension. This
will require isolation of novel, salt-tolerant enzymes, e.g., to be produced
by Bacillus species isolated from the Red Sea. Hydrolyzed biomass,
suspended in saline water, will be used for microbial fermentation to
produce high value chemicals. Cell factories for these processes will
also be isolated from the Red Sea. Running the fermentation process
with saline water will reduce (1) the risk of contamination, which will
reduce costs for sterilization, and (2) the cost incurred from energy
consumption for saline water desalination
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large knowledge base, both in terms of genetics and physiol-
ogy and in terms of industrial scale production. The largest
market for fermentation products, by far, in terms of volume is
ethanol, which is used as a biofuel. Ethanol is predominantly
produced in the USA and in Brazil from corn and sugar cane,
respectively. This process has become the benchmark for
many other industrial fermentation processes, both in terms
of defining bioprocessing costs and in terms of defining re-
quirements for the cell factory. It is a relatively low-cost pro-
cess as there is no need for aeration. The rapid production of
ethanol prevents, to a large extent, contamination of the bio-
reactor, which means that costs for sterilization can be reduced
or even completely eliminated. Based on Fig. 1, we envisage
that by using highly saline water from the Red Sea combined
with salt-tolerant cell factories, it will similarly be possible to
establish bioprocesses that have similarly reduced (or no)
costs for sterilization of the feedstock. Below we will discuss
some of the challenges associated with development of novel
bioprocesses and thereafter describe a few bioprocesses intro-
duced in recent years due to either the ability to reduce costs
and environmental footprint or to provide new chemicals.
Challenges in developing new bioprocesses
As mentioned in the introduction, there are three key chal-
lenges in connection with developing of a bioprocess: (1)
developing of the biocatalyst, or cell factory; (2) ensuring
feedstock for the bioprocess; and (3) developing a cost effi-
cient bioprocess. The key challenge in connection with devel-
oping a novel bioprocess is the engineering of an efficient
biocatalyst, i.e., the cell factory, and typical costs for develop-
ing a novel bioprocess amounts to US$50–100 million,
whereof a major fraction is for cell factory development
(Nielsen and Keasling 2016). Development of a cell factory
involves the following steps (Nielsen and Keasling 2016): (1)
molecule identification; (2) pathway identification; (3) recon-
struction of relevant pathway in chosen cell factory; and (4)
optimization of the titer, rate, and yield (TRY) required for a
cost competitive process. Molecule identification will typical-
ly come as input from the industry segment where the chem-
ical is going to be applied and requires a detailed analysis of
market developments as well as the associated intellectual
property, i.e., it is possible to obtain freedom to operate in
Table 1 List of key chemicals
produced from renewable sources Industry segment Chemical Cell factory Key producers
Fuels Ethanol S. cerevisiae Many
Isobutanol S. cerevisiae Gevo, Butamax
Farnesene S. cerevisiae Amyris/Total
Bulk 1,3 Propanediol E. coli DuPont
1,4 Butanediol E. coli Genomatica/BASF/
Novamont/Cargill
Lactic acid pH-tolerant yeast Cargill
Feed ingredients Lysine C. glutamicum Ajinomoto, Evonik, CJ, ADM
Threonine E. coli
C. glutamicum
Ajinomoto, Evonik, ADM,
Chiel Jedang
Food ingredients Glutamate C. glutamicum Ajinomoto
Citric acid A. niger, A. wentii Cargill, ADM
Pharmaceuticals Penicillin P. chrysogenum Many
7-ADCAa P. chrysogenum DSM
Artimisinic acid S. cerevisiae Artepharm, Amyris/Sanofi-
Avensis
Hydrocortisone S. cerevisiae Sanofi-Avensis
Vitamins etc. Riboflavin A. gossypii, B. subtilis BASF, DSM
EPAb Y. lipolytica DuPont
Resveratrol S. cerevisiae Evolva
Industrial enzymes Many A. niger, A. oryzae, Bacillus
species
Novozymes, DuPont, DSM
Fine chemicals Sesquiterpenes S. cerevisiae Amyris, Evolva
a 7-aminodesacetoxycephalosporanic acid
b Eicosapentaenoic acid
c A large number of different industrial enzymes are produced for use in the food, feed and starch industries
d Today, several different sesquiterpenes used as perfume ingredients are produced by fermentation
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terms of engineering of the cell factory and subsequent pro-
duction in countries of interest. When a proper molecule has
been identified, the next step is to identify if there is a known
biological route for biosynthesis of this molecule. With the
immense biological variability, it is often possible to find a
suitable metabolic pathway leading to the chemical of interest,
but in some cases, it may be necessary to develop novel en-
zymes, which is challenging but feasible.When a pathway has
been identified, the genes encoding the individual enzymes
will be cloned into the cell factory chosen for the production
process. Asmentioned earlier, there is a tendency to use one of
the few cell factories as production platform, generally re-
ferred to as cell factory platforms.
There are several reasons why industry prefers to use a few
cell factory platforms: (1) Cell factory development typically
involves extensive engineering of the cellular metabolism and
therefore involves several rounds of the so-called Design-
Build-Test (DBT) cycle (Fig. 2). It is therefore advantageous
to use extensively studied organisms, like Saccharomyces
cerevisiae and Escherichia coli. These two are arguably the
best studied microorganisms, with a wealth of knowledge
available, both at the genome level, i.e., extensive omics data,
and at the molecular level, e.g., at the enzymology level, and it
is therefore easier to engineer these for improving the TRY.
However, for some products, these organisms are not well
suited and other cell factories are therefore chosen in these
cases. For instance, S. cerevisiae and E. coli are not well suited
for high-level secretion of proteins, and Aspergilli and Bacilli
are therefore often used as cell factories for production of in-
dustrial enzymes. Furthermore, Corynebacteria are very effi-
ciently producing and secreting amino acids and are therefore
used for production of amino acids and hereof derived prod-
ucts. (2) In order to engineer the cell factory, it is necessary to
have good genetic tools. This again favors well-studied organ-
isms like S. cerevisiae and E. coli, but with the introduction of
CRISPR-Cas9 technologies, it is becoming possible to easily
engineer many other cell factories. (3) It is important to have
organisms that are tolerant to industrial-like conditions. In
many cases, industrial fermentations are carried out using com-
plex feedstocks that may cause high osmotic pressure, low pH,
and high temperatures. Organisms that have proven to tolerate
these conditions will be preferred, as it is generally difficult to
engineer the organism to have improved tolerance (generally
characterized as complex traits). (4) Finally, it is important to
have knowledge on how the cell factory functions at large
scale, i.e., does prior knowledge exist about how studies in
the laboratory translates to large-scale fermentation processes.
It is quite expensive to scale-up a process and it is therefore
important to have knowledge from previous scale-up studies
with the same cell factory. The move towards the use of a few
cell factories is best illustrated by the enzyme industry.
Traditionally, many different cell factories were used for pro-
duction of different enzymes, but today leading companies like
Novozymes and DuPont rely on the use of a few cell factory
platforms, e.g., A. niger, Aspergillus oryzae, Bacillus subtilis
and Bacillus clausii. The use of only a few cell factory plat-
forms has allowed the industry to rapidly develop a production
process for a new enzyme, as the technology basically be-
comes plug-and-play where the gene encoding a new enzyme
is simply inserted into an efficient enzyme producer, and the
resulting cell factory can be transferred to large-scale produc-
tion following a few tests in the laboratory.
Even though it may be challenging to reconstruct a biosyn-
thetic pathway in a given cell factory, this has now been dem-
onstrated for a wide variety of products (Wang et al. 2012; El
Zoeiby et al. 2001; Rugbjerg et al. 2013; Xu et al. 2012; Li et al.
2011; Sun et al. 2010). The choice of cell factory depends on
the properties of the product and the pathway to be reconstruct-
ed. Thus, for commodity-like products, where high rates are
important for the economics of the process, E. coli is to be
preferred, as illustrated by the use of this cell factory for the
production of 1,3-propanediol (Emptage et al. 2003; Diaz-
Torres et al. 2000) and 1,4 butanediol (Yim et al. 2011).
However, if the product is an organic acid, it is preferential to
use an organism that can tolerate low pH as the product can
hereby be produced directly in its acid form. A. niger is there-
fore used for production of citric acid, and a low pH-tolerant
yeast was chosen by Cargill for the development of their new
lactic acid production process (Rush 2012). For reconstruction
of complex plant pathways, S. cerevisiae is typically preferred
over E. coli, as it is difficult to express P450 enzymes in bacteria,
which is illustrated by the production of both resveratrol (Mei
et al. 2015) and hydrocortisone (Szczebara et al. 2003) using
S. cerevisiae. The reconstruction of a plant pathway in yeast
Fig. 2 Development of a cell factory. a A reference strain, e.g., a strain
that can efficiently convert sugars to ethanol, is engineered by first
reconstruction of a novel pathway that leads to the product of interest,
here illustrated as a red pathway towards isobutanol. Thereafter, the cell
factory is engineered such that the majority of the sugar is converted to the
desired product and no (or little) sugar is converted to ethanol (the original
product). The last step is to ensure that the engineered strain has the right
titer, rate, and yield (TRY) metrics to allow for cost-competitive
production of chemical. b In order to reach the TRY targets for
industrial implementation, it is generally necessary to perform extensive
engineering of the cell factory. This involves several rounds of the so-
called Design-Build-Test (DBT) cycle. Here designs are developed based
on physiological knowledge or throughmathematical modeling and these
designs are being built into the strain. The engineered strain(s) are then
tested, preferentially at industrial-like conditions. By going through the
DBT cycle, much knowledge is gained about the physiology of the cell
factory, and it is important to accumulate this knowledge and learn from
each design step
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was recently taken to the extreme by expressing a 23 enzymatic
step pathway for production of opioids (Galanie et al. 2015),
but even though the opioids were produced in low levels, it was
necessary to engineer the yeast endogenous metabolism to en-
sure product formation (Galanie et al. 2015). Reconstruction of
a biosynthetic pathway in the cell factory of choice is an im-
portant step towards industrial production, but as mentioned
above, it is subsequently necessary to improve the TRYin order
to establish a process. Improving the TRY generally involves
many rounds of the DBT cycle and is therefore costly. The
reason for this is that metabolism in all organisms has evolved
to serve specific purposes, e.g., for yeast to rapidly convert
sugars to ethanol in order to capture energy needed for growth
and at the same time make a toxic product that prevents growth
of competitors. This means that extensive regulatory systems
have evolved to ensure that the metabolism is operating robust-
ly, even when the cells are exposed to various perturbations.
Due to this tight regulation, it is difficult to redirect the fluxes
inside the cell, e.g., to redirect the metabolism from efficiently
producing ethanol to producing farnesene.
Whereas the major challenge in developing a new
bioprocess is with developing the cell factory, there are also
challenges associated with matching the cell factory design
with the feedstock that is going to be used for the production.
In the bioethanol industry, different yeast strains are used for
production in Brazil, where the feedstock is sugar cane (Basso
et al. 2008), and in the USA, where the feedstock is primarily
corn (Song et al. 2016). Thus, for designing a new bioprocess, it
is important to have in mind what the feedstock is going to be
for the final bioprocess. The cell factory can be engineered to
adapt to alternative feedstock, as illustrated by the extensive
engineering of S. cerevisiae to use lignocellulosic hydrolysates
as a feedstock (Matshushika et al. 2009), and which has now
resulted in initiation of second generation ethanol production.
Another important aspect to consider is how the fermentation
will be integrated with downstream processing and purification
of the product. This may have an impact on the cell factory
choice and on the design criteria for the cell factory, in particular
on how it is going to be tested in each round of the DBT cycle.
Lower costs, stable production, and lower
environmental footprint
For a number of chemicals that have traditionally been pro-
duced from petrochemicals or by extraction from plants, the
chemical industry has been seeking to establish bio-based pro-
duction, for primarily the three following reasons: (1) to reduce
costs, (2) to ensure stable production, and/or (3) to reduce the
environmental footprint. Two of the early examples of this were
the development of a process for bio-based production of ribo-
flavin by BASF and of 7-ADCA by DSM. Riboflavin (vitamin
B2) is used both as a dietary supplement for humans and in
feed, and is therefore produced in large volume. Traditionally,
riboflavin was produced through chemical synthesis, but by
developing a riboflavin-producing bioprocess through engi-
neering of the filamentous fungus Ashbya gossypii, BASFwere
able to reduce the associated water emissions by 67% and car-
bon dioxide emissions by 80%, primarily due to reduced energy
and water usage (Ledesma-Amaro et al. 2015). 7-ADCA is a
precursor for production of the widely used antibiotics cepha-
lexin, and traditionally, 7-ADCA was produced chemically
from penicillin. However, by metabolic engineering, a high-
yielding strain of Penicillium chrysogenum, DSM, established
a process for production of adipoyl-7-ADCA that can easily be
enzymatically cleaved to adipic acid and 7-ADCA. The
bioprocess reduced carbon dioxide emissions by 5% and re-
duced water and energy usage by 75% and 20%, respectively
(Erickson and Hessler 2004).
Many chemicals are obtained from plant sources.
Typically, their chemical structure makes them difficult to
chemically synthesize and it is therefore cheaper to extract
them from plants, even though the yields are very low. A good
example of this is artemisinin, which is one of the most effi-
cient antimalarial drugs (WHO 2016). This compound is ex-
tracted from Artemisia annua, sweet wormwood. There have
been large variations in supply, primarily because of the long
time between planting and harvest, i.e., farmers have planted
extensivelywhen supplywas low (and price high), resulting in
over-production and dropping prices a few years later. In order
to ensure a more stable production, Prof. Jay Keasling and his
research group at the University of California Berkeley under-
took a large metabolic engineering project on developing a
bioprocess for production of artemisinin. Initial work was
done in E. coli (Tsuruta et al. 2009), but as it was hard to
express P450 enzymes in this organism, the group switched
to yeast as a cell factory (Ro et al. 2006). Following initial
development at University of Berkeley, the work was trans-
ferred to Amyris, who later partnered with Sanofi-Avensis for
industrial production. The research and development work
was to a large extent financed by the Bill & Melinda Gates
Foundation, who required that the companies involved should
sell artemisinin not-for-profit. In 2014, this process reportedly
delivering more than 337 million doses of artemisinin-based
combination therapies (ACTs), successfully reducing the
global malaria burden (WHO 2016). The engineering of yeast
for efficient production of the chemical was a major undertak-
ing and involved identification of novel enzymes, engineering
of yeast endogenous metabolism and further chemical conver-
sion to obtain the final product (Ro et al. 2006; Westfall et al.
2012; Ro et al. 2008; Paddon et al. 2013). Another plant prod-
uct for which there has been developed a bioprocess for pro-
duction is resveratrol. This chemical is an antioxidant present
in grapes and it is sold as a dietary supplement. Traditionally,
it was extracted from Japanese knotweed, but the company
Fluxome reconstructed the resveratrol biosynthetic pathway in
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yeast, and through further metabolic engineering, a yeast
strain was developed that could produce cost-competitive res-
veratrol resulting in a commercial process (Smits et al., 2011).
In 2012, the technology was acquired by Evolva, who is today
marketing yeast based resveratrol (Baerends et al. 2014).
Resveratrol is derived from either tyrosine or phenylalanine,
but it also requires efficient provision of malonyl-CoA and
efficient production therefore requires a number of different
metabolic engineering steps (Li et al. 2015). Sesquiterpenes
are another class of plant metabolites for which there has been
much interest in establishingmicrobial fermentation processes
for their production. This is a wide group of chemicals (in the
class of isoprenoids) that find many different applications, e.g.
perfume ingredients and pharmaceuticals. Through collabora-
tion with Firmenich, we were involved in the early develop-
ment of a yeast platform for production of sesquiterpenes to be
used as perfume ingredients (Asadollahi et al. 2009). The
perfume ingredient industry is interested in producing their
chemicals using microbial fermentation, as this will enable
scalable production and independence from fluctuations in
the supply of the plant raw material. Through several rounds
of the DBT cycle, we managed to significantly improve the
production of α-santalene, normally extracted from sandal
wood oil (Schalk and Clark 2007). Today, Firmenich and
other companies have partnered with Amyris and/or Evolva
for production of many of their perfume ingredients.
Chemical building blocks used for production of plastic
polymers are among the chemicals produced and sold in larg-
est volumes. Thus, 1,3 propanediol, traditionally produced by
chemical synthesis, used in the production of plastic, deter-
gents, adhesives, composites, antifreeze and heat-transfer in-
dustrial fluids coatings, polyurethanes and cosmetics, and 1,4
butanediol, traditionally produced from petroleum-derived
feedstock used in the production of plastic, elastic fiber, and
polyurethanes are each produced in large volumes. In connec-
tion with the development of their new polymer Sorona®,
DuPont were, however, interested in developing a bio-based
production as this would allow them to reduce costs and also
the environmental footprint. Through collaboration with
Genencor, they performed extensive metabolic engineering
of E. coli and thereby developed a cell factory for production
of 1,3 propanediol (Nakamura and Whited 2003). In collabo-
ration with Tate & Lyle, they further developed a completely
new bioprocess, which was necessary as this was the first
large-scale production process using E. coli as a cell factory.
The development of this process represents one of the mile-
stones in bio-based production as it was the first example of
complete metabolic engineering of a cell factory for produc-
tion of a non-natural-produced chemical combined with de-
velopment of a novel bioprocess for large-scale production.
More recently, Genomatica performed metabolic engineering
of E. coli for production of 1,4 butanediol (Yim et al. 2011).
Through several rounds of the DBT cycle, they obtained an
E. coli strain that could produce more than 18 g/L in a 140-h
fermentation process (Yim et al. 2011). Through partnering
with BASF, Novamont, and Cargill, they developed a com-
mercial process for production of 1,4 butanediol, which here-
by became the second commodity type chemical produced by
microbial fermentation (Burgard et al. 2016).
New chemicals with desirable properties
The chemical industry is constantly looking for chemicals with
new, interesting properties. A classic example of this is the
invention of nylon by DuPont in the 1930’s. The very high
oil prices around 2008 resulted in the establishment of a large
number of projects and biotech companies focusing on produc-
tion of advanced biofuels, i.e., chemicals that have improved
properties compared with ethanol. Ethanol is in many ways an
excellent drop-in fuel, but it does have some drawbacks: (1) its
energy content is quite low and (2) it is hydroscopic, i.e., it
attracts water and it is therefore not suitable for use in boat
engines, and this also makes it unsuitable for transport via pipe-
lines. There has therefore been much interest in producing bu-
tanol, which has a higher energy density and is less hydroscopic
than ethanol, and is therefore an ideal drop-in fuel in gasoline.
Furthermore, isobutanol can easily be chemically converted to
isobutylene, which is used to make isooctane, isooctene, and jet
fuel. This resulted in two large initiatives for production of
isobutanol, one driven by Butamax, a joint venture between
DuPont and BP, and the other driven by Gevo (Hong and
Nielsen 2012). Both companies performed extensive metabolic
engineering of yeast in order to develop a cell factory that could
meet the TRY requirement for production of isobutanol, and
currently Gevo is producing isobutanol commercially. Another
large initiative has been driven by Amyris, who used their yeast
platform strain for production of farnesene, which is a sesqui-
terpene derived by a single enzymatic step from the endoge-
nous yeast metabolite farnesylpyrophosphate (Hong and
Nielsen 2012; Tippmann et al. 2016). In 2010, Amyris
partnered with Total on development of this process, and even
though the yeast cell factory is still being further improved,
Amyris is producing farnesene to be used as jet fuel and as a
drop in fuel in diesel for busses in Brazil.
In the last couple of years, there has been much focus on
production of other types of hydrocarbons, in particular alkane
and alkenes. This was initiated by the identification of the
enzymes responsible for the conversion of fatty acids to al-
kanes and reconstruction of these in E. coli (Choi and Lee
2013). Today many more enzymes have been discovered
(Kang and Nielsen 2016) also allowing for production of short
chain alkanes/alkenes in E. coli (Choi and Lee 2013).
Recently alkane production was also demonstrated in
S. cerevisiae (Buijs et al. 2015; Foo et al., 2017) and through
engineering of the fatty acid production, it was demonstrated
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possible to improve the production of alkanes/alkenes signif-
icantly (Zhou et al. 2016).
As mentioned above, another example of a new chemical
introduced is polylactic acid (PLA), a polymer derived from
lactic acid. Polymer chemists at Cargill identified a route for
production of PLA, in which a very pure form of the L-isomer
is required for production of polylactic acids with high melt-
ing point and high crystallinity (Lunt 1998). Lactic acid,
which is used in the food industry for preservation, is tradi-
tionally produced by fermentation of lactic acid bacteria
(LAB), but these cell factories require complex media as they
are auxotrophic for several amino acids. It is therefore costly
to obtain a pure form of lactic acid and this led Cargill re-
searchers to look for an alternative cell factory that could grow
on a minimal medium. They added the ability to grow and
produce lactic acid at low pH as an additional criterion, as this
would allow them to produce lactic acid directly and not lac-
tate, as produced by LAB. As it is the lactic acid that is re-
quired for polymerization, the use of lactate would require a
conversion to lactic acid through addition of an inorganic acid
and this would result in production of 1.2 kg of gypsum per
kilogram of lactic acid produced. Their search resulted in the
identification of a low pH-tolerant yeast species that they
could eventually engineer to efficiently produce lactic acid
and convert this further to PLA (Rush 2012). This resulted
in establishment of a 140,000-metric tons/year production
plant of PLA in Blair, Nebraska, USA (Nature Works LLC
2005). This case is interesting as it is a clear demonstration
that it may be beneficial to use a non-conventional cell factory
for a new bioprocess. It required significant investments by
Cargill to develop the genetic tools for metabolic engineering
of their yeast strain, but they are now offering the yeast strain
together with tools as a technology package for other compa-
nies interested in producing organic acid. This has recently
been exploited by BioAmber for production of succinic acid
(Hartmann 2010), which is of much interest as a chemical
building block for a variety of polymers, that is, bio-based
succinic acid can be transformed into 1,4-butanediol (BDO)
and tetrahydrofuran (THF) in a single catalytic step (Cavani
et al. 2016).
Harnessing the biodiversity of the Red Sea:
Transition to renewable resources
The Middle East countries currently have a largely oil-
dependent industry and infrastructure, which results in very
high carbon emissions per capita; e.g. 55 tons per capita in the
United Arab Emirates, compared to only 22 tons per capita in
the US (Zafar 2017). To change this trend, the region is antic-
ipating investments in renewable energy in the order of $35
billion per year by the year 2020 (Zafar 2017). However,
many countries in the region have severe limitations in
producing biomass to replace oil, simply because the arable
land is very scarce. For example, Saudi Arabian territory is
mostly desert, and only 1.5% of the land is arable (Crop Trust
2017). A viable alternative for such countries is to turn to
photosynthetic sea organisms for biomass production and en-
gineering of cell factories.
The Red Sea is a prime example of such an alternative bio-
resource. It stretches approximately 2250 km in length, but it
is largely an isolated body of water, as the southern opening is
merely a narrow passage to the Indian Ocean and there are no
rivers flowing into it. This desert bound sea exhibits consis-
tently high salinity gradient (36–41 p.s.u) owing to high sur-
face evaporation in the north, and maintains a uniform tem-
perature of 21.5 °C below the heated (28–32 °C) surface layer.
Consequently, this body of water is uniquely warmer, has low
nutrient content and is hypersaline with more than 10% of the
fish species being endemic (Di Battista et al. 2013). It is an
implied evolutionary incubator that occasionally exports spe-
cies into the adjacent Indian Ocean (Di Battista et al. 2013).
The diverse Red Sea ecosystem includes reef sharks, dolphins,
turtles, stingrays, sea urchins, sea cucumbers and a huge vari-
ety of corals, sponges, mollusks and smaller fish species. All
these depend on the hypersaline adapted bacteria and archaea
to maintain ecological balance of the reef. This particular eco-
logical niche represents an untapped potential for developing
efficient cell factories along two main axes (Fig. 1). Firstly, it
could be expected to provide access to new salt-tolerant,
thermotolerant and organic solvent-tolerant enzymes and spe-
cific metabolic pathways that evolved in this particular envi-
ronment (Khandeparker et al. 2011; Xin and Hui-Ying 2013;
Yu and Li 2014). Those features are particularly interesting for
industrial processes, and could significantly expand our syn-
thetic biology toolbox. Secondly, the ability of local organ-
isms to grow in a high salinity environment could lead to
isolation of saline-tolerant cell factories that can be used for
biosustainable production of fuels and chemicals using saline
water as a source for production. This would considerably
reduce the risk of contamination and bypass the requirement
for desalination, which is extremely expensive and generates a
large environmental footprint. Under the economic diversifi-
cation plan BVision 2030^, Saudi Arabia aims to take a
regional lead in the process of developing new technologies
for bio-based production of high value chemicals by Red Sea
microorganisms. The King Abdullah University of Science
and Technology (KAUST) therefore runs a broad research
program aiming to deliver the key enabling technologies for
this transition to bio-based economy. In the previous sections
we have outlined and discussed the key global drivers for the
shift to bio-based production: expanding the range of mole-
cules produced by cell factories, and reducing the price and
the environmental footprint of the production. The main chal-
lenges we outlined are the correct choice of the cell factory,
development of engineering tools, and matching the desired
Appl Microbiol Biotechnol (2017) 101:4837–4851 4843
product with access to feedstock and the metabolic capacity of
the cell factory. In the following sections, we will discuss how
these particular challenges could be addressed in the region,
using the biodiversity potential of the Red Sea. We will focus
on screening for the most promising cell factories that can be
derived from the local environment, and production processes
that match the metabolic setup of the local cell factories and
the available carbon sources.
Hypersaline adapted bacteria inhabiting the Red Sea
The unique Red Sea ecosystems epitomize huge opportunities
for successful identification of novel biocatalysts, as well as
microbial cell factories. Consequently, diverse Red Sea asso-
ciated microbiomes have been the focus of several recent stud-
ies at KAUST, including those from different environments:
mangrove sediment (Al-Amoudi et al. 2016a; Al-Amoudi et al.
2016b; Alzubaidy et al. 2016; Simões et al. 2015), sea water
(Qian et al. 2011; Jimenez-Infante et al. 2016), coral (Bayer
et al. 2013), sponge (Gao et al. 2015; Tian et al. 2014), and
extreme niches such as Red Sea brine pools (Mwirichia et al.
2016; Zhang et al. 2015; Kamanda Ngugi et al. 2015; Siam
et al. 2012; Abdallah et al. 2014; Antunes et al. 2015; Behzad
et al. 2016; Jimenez-Infante et al. 2014; Grötzinger et al. 2014).
Such studies focused on relevant microbial bioactivities, such
as for example antibacterial activity (Sagar et al., 2013a, b;
Moitinho-Silva et al. 2014; Abdelmohsen et al. 2014).
Metagenomics studies of Red Sea samples show a distinctive
composition of local microbiota, quite distinct from other ma-
rine environments (Thompson et al. 2013). This is a specific
consequence of the 25 Red Sea brine pools, thought to be
inhospitable to organic life, harboring bacteria that thrive in
these hydrothermal and hypersaline deep-sea environments
(Mwirichia et al. 2016; Zhang et al. 2015; Kamanda Ngugi
et al. 2015; Grötzinger et al. 2014; Siam et al. 2012;
Abdallah et al. 2014; Antunes et al. 2015; Behzad et al.
2016; Jimenez-Infante et al. 2014). An interesting study of
vertical stratification was reported for two hydrothermal and
hypersaline deep-sea pools in the Red Sea: the Atlantis II and
Discovery. A metagenomic study of the two deep-sea pools
showed that alpha-Proteobacteria dominated the deep sea,
Planctomycetaceae, or Deferribacteres dominated the brine-
seawater interfaces, while gamma-Proteobacteria dominated
brine pools (Bougouffa et al. 2013). Multivariate analysis of
the data indicated that temperature and salinity were the two
major influences shaping the composition of these communi-
ties. From the metagenome analysis, a novel mercuric reduc-
tase was derived, which was collected from the lower convec-
tive layer (LCL) of the Atlantis II (ATII) deep brine pool
(Sayed et al. 2014). The amino acid sequences for this ATII-
LCL mercuric reductase differs from the soil derived orthologs
by only <10% but exhibits striking functional differences as it
is in vivo functional in high salt, stable at high temperature,
efficiently detoxifies, and is resistant to increased levels of
Hg2+ in vivo (Sayed et al. 2014). This indicated that the Red
Sea extremophiles have developed specific metabolic path-
ways and enzymes to cope with their environment, and they
can clearly serve as a source for potential biotechnology-based
applications. Genomes of several microorganisms with unusu-
al features were also isolated and sequenced, such as
Candidatus Synechococcus spongiarum (Gao et al. 2014), a
sponge symbiont, and several extremophiles isolated from the
deep-sea anoxic brine lakes, includingHaloplasma contractile
(Antunes et al. 2011a), Halorhabdus tiamatea (Antunes et al.
2011b), and Salinisphaera shabanensis (Antunes et al. 2011c).
Haloplasma contractile was reported to represent a new order
situated between Firmicutes and Mollicutes (Antunes et al.
2011a). This bacterium has an unusual morphology with con-
tractile protrusions. In line with this observation, its genome
harbors an unusually high number ofMreB/Mbl homologs that
are known to play a role in cell morphogenesis. Halorhabdus
tiamatea is the first archaeon isolated from deep-sea anoxic
brine lakes (Antunes et al. 2011b). A genome comparison with
Halorhabdus utahensis suggests that H. tiamatea has signifi-
cantly more transmembrane transport genes and a putative tre-
halose synthase and lactate dehydrogenase (LDH). Trehalose
synthase has never been detected in other members of
Halobacteriaceae. Also, no LDH homologs had been detected
in haloarchaeal genomes, even though LDH activity has been
reported in Halobacterium salinarum cell extracts (Bhaumik
and Sonawat, 1994).
Since most of the downstream experiments conducted on
isolated strains critically depend on findings in the initial
metagenomic screens, and because the detailed functional an-
notation of newly sequences microbial genomes is time-
consuming due to integration of variety of experimental and
computational data, a pipeline for Automatic Annotation of
Microbial Genomes (AAMG) was developed (Alam et al.
2013). This annotation pipeline can be accessed through
INDIGO web server (freely available at http://www.cbrc.
kaust.edu.sa/indigo). INDIGO is a data warehouse system
that not only provides integration of annotations for
exploration of information but also enables detailed analysis
of newly sequenced microbial genomes.
Identification of novel cell factories from the Red Sea
isolates
As discussed above, the choice of the cell factory and matching
the desired product to the metabolic makeup of the cell factory
are the key challenges for developing bio-based production.
The efforts in this direction started with large screening initia-
tives, focused on finding potential cell factories in environmen-
tal samples from the Red Sea. The first study that compared
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Red Sea lagoon microbiomes in terms of diversity, taxonomy,
and antimicrobial effects was finalized in 2016 (Al-Amoudi
et al. 2016b). The study explored mangrove mud and the mi-
crobial mat sediments collected from the Rabigh harbor lagoon
(RHL) and Al Kharrar lagoon (AKL) for antimicrobial
bioprospecting. Results suggested that the mangrove mud sam-
ples are superior in terms of taxonomical abundance, species
diversity, percentage ofDNA sequences for enzymes associated
with antibiotic synthesis, polyketide synthases (PKS), and
nonribosomal peptide synthetases (NRPS), compared to micro-
bial mat samples from salt marsh. Moreover, the antibiotic bio-
synthesis activity related to PKS or NRPS was higher in
Firmicutes (Bacilli and Clostridia) compared to other phyla.
Interesting conclusions could be drawn when correlating the
community composition of the mangrove mud samples with
hydrocarbon content. The samples from the non-industrialized
AKL site show a shift in dominant phyla consistent with early
hydrocarbon contamination exposure, similar to those reported
for the Prestige oil spill metagenomic samples collected in
2004, which was dominated by Proteobacteria (primarily com-
prised of gamma- and delta-Proteobacteria) (Acosta-Gonzalez
et al. 2013). The mangrove mud samples from the industrial-
ized RHL site exhibit a shift in terms of dominant phyla con-
sistent with late hydrocarbon contamination exposure, similar
to the Prestige oil spill metagenomic samples collected in 2007
(Acosta-Gonzalez et al. 2013). The correlation to exposure to
hydrocarbon contamination highlighted an interesting feature
of the proportion of Firmicutes, which is highest in the pristine
mangrove mud (Alzubaidy et al. 2016), followed by the AKL
mangrove mud, and lowest in the RHL mangrove mud. This
indicated that the more robust Firmicutes (Bacilli and
Clostridia) with potential to produce secondary metabolites of
interest can be cultured from the RHL mangrove mud samples.
To experimentally screen for the in silico detected potential
for synthesis of antimicrobials, traditional culturing methods
were applied (Al-Amoudi et al. 2016a). Screening the cultured
strains for antimicrobial activity confirmed the in silico detected
presence of PKS andNRPS, sincemost of the positive screening
results were from Firmicutes (Al-Amoudi et al. 2016a).
Moreover, 10 of the strains displayed zone inhibition against
all three-indicator used pathogens, of which nine strains belong
to the phylum Firmicutes, while one belongs to the phylum
Proteobacteria. Since PKS and NRPS have been found to sup-
port synthesis of secondary metabolites that act as antibiotics,
immunosuppressants, toxins, siderophores, or antitumor agents
(Amoutzias et al. 2016), their presence increases chances of
identifying organisms capable of producing the abovementioned
bioactive secondary metabolites. For the 10 strains displaying
zone inhibition against all three-indicator pathogens, PKS and/or
NRPS gene sequences were found to be present in strains be-
longing to species Bacillus licheniformis, Bacillus vallismortis,
B. subtilis, and Paenibacillus dendritiformis. The remaining
strains (belonging to species Bacillus sonorensis, Brevibacillus
borstelensis, andAneurinibacillusmigulanus) did not have iden-
tifiable PKS and/or NRPS genes and thus possibly harbor novel
biosynthetic clusters with capacity to synthesize antibacterial
compounds. Some of these species may very well serve as
completely novel cell factory platforms in the future, where
sea water can be used for low-cost bioproduction of bioactive
compounds.
From the abovementioned samples, several amylase and
lipase enzymes were identified in both the AKL and RHL
metagenomic datasets; most of which were derived from
Bacilli (Al-Amoudi et al. 2016b). Amylases and lipases are
important industrial biocatalysts used in several industries that
require thermostable enzymes suitable for starch degradation
and production of glucose, maltose, and dextrose (Asgher
et al. 2007; Gomes et al. 2003), as well as enzymes that remain
active in industrial processes where concentrated salt solutions
are used (Prakash et al. 2009). Halobacterial enzymes are
found to be thermotolerant and stable at room temperature
for extended periods (Mohapatra et al. 1998). Several thermo-
stable α-amylase have been derived from Bacilli strains such
as Bacillus stearothermophilus and B. licheniformis (used in
starch processing industries) (Gomes et al. 2003), as well as
halophilic amylases derived from Chromohalobacter sp.
(Prakash et al. 2009), Halobacillus sp. (Amoozegar et al.
2003), Halomonas meridiana (Coronado et al. 2000), and
Bacillus dipsosauri (Deutch 2002). Bacillus is also one
of several microbial genera used for the commercial produc-
tion of lipases (Aravindan et al. 2007). The search for thermo-
stable lipases continues, and several such thermostable lipases
have been isolated and characterized primarily from Bacilli
(Kumar et al. 2014; Kumar et al. 2005; Castro-Ochoa et al.
2005). Owing to the extreme characteristics of these Red Sea
lagoons, Bacilli strains from these environments could be ex-
pected to be extremely robust in other extreme environments,
including high density production conditions, since they dem-
onstrated tolerance in ecosystems exposed to hydrocarbon
contamination. They could be expected to harbor the halophil-
ic thermostable amylases and lipases required by industry as
biocatalysts. The overall outcome of these screening initia-
tives suggests that the local Bacilli represent an important
source of industrially relevant enzymes and new antimicro-
bials, and their development into cell factories could be a
plausible route for bio-based production in the region.
Cyanobacteria: the potential to derive biomass
from solar energy
The remaining important challenge in developing bio-based
processes is the feedstock availability. As discussed above,
with very limited arable land in the region calls imposes dras-
tic restrictions on producing terrestrial plant biomass.
Photosynthetic sea organisms should thus be a preferred
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choice. Cyanobacteria are very abundant photosynthetic bac-
teria, with a widely recognized potential to produce secondary
metabolites and biofuels (Cassier-Chauvat et al. 2017). They
have a complex metabolism, and the regulatory mechanisms
that coordinate the light harvesting module with the biosyn-
thetic modules have been extensively modeled in silico
(Westermark and Steuer 2016). Diversity of hydrocarbons
produced by Cyanobacteria in terms of chain length, degree
of saturation, and variations of the carbon skeleton has been
highlighted by Xie et al. (2017). Considerable efforts have
been directed to metabolic engineering of Cyanobacteria,
mainly geared towards biofuel production (Al-Haj et al.
2016; Oliver et al. 2016; Johnson et al. 2016; Gomaa et al.
2016). The major optimization strategies were directed to-
wards improving carbon fixation (Atsumi et al. 2009), im-
proving the capture of the light energy (Iwaki et al. 2006),
and improving product extraction by the use of induced autol-
ysis systems (Miyake et al. 2014).
With the global horizontal irradiance ranging between
5700 to 6700 Wh/m2, Saudi Arabia has one of the highest
solar energy potentials on the planet. On the other hand, the
scarcity of fertile soil limits the availability of plant biomass,
which is the basic resource for this type of biotechnology
worldwide. Cyanobacteria, with their capacity to capture solar
energy and convert CO2 to sugars, and ultimately biomass,
present a promising solution to bridge this gap. The major
hurdle that has to be overcome is the relatively slow growth
of Cyanobacteria, compounded by the fact that simple ad hoc
strategies to improve product yield have been largely unsuc-
cessful (Ruffing 2013; Liu et al. 2011; Oliver et al. 2016;
Wang et al. 2013). To overcome this hurdle, more comprehen-
sive metabolic optimization strategies are needed to guide the
engineering of Cyanobacteria for increased growth rate and
biomass production. The KAUST research program for devel-
oping new technologies for bio-based production has isolated
a large number of Cyanobacterial species from the local envi-
ronmental samples that show potential as producers of bio-
mass. They can be potentially used for production or animal
and fish feed, and those that have advantageous properties of
lipid metabolism could be geared towards the production of
biofuels. To facilitate the use of these isolates, KAUST has
developed a computational framework to guide genome re-
duction of cyanobacterial strains with the aim of generating
the so-called Bclean^ genomes that retain all genetic compo-
nents necessary for the organism to survive and yet remain
able to sustain production of desired chemicals. Additionally,
the reduced genome is expected to have improved genome
stability and possibly an improved growth rate. It should be
noted that some Cyanobacteria possess small genomes but
exhibit high ploidy level that is growth phase-regulated
(Greise et al. 2011), and this should be taken into account
when genome reduction is attempted. The key feature of this
computational framework is that it guides genome reduction
and does not require the availability of a sequenced genome of
a closely related strain. Thus far, genomic islands and pro-
phage components that could be eliminated from genomes
of the strains from cyanobacterial genus Synechococcus have
been identified (Bajic VB and EssackM, unpublished results).
The same approach was applied to the Bacilli isolated from
the Red Sea: Bacillus foraminis, B. licheniformis, Bacillus
amyloliquefaciens, Bacillus niabensis, B. vallismortis, and
Bacillus acidicola strain. The strategy chosen was inspired
by Posfai et al. (2006) who demonstrated that the reduction
of the E. coli K-12 MG1655 genome by ∼15% via genetic
engineering (aimed to obtain the Bclean^ genome) achieved a
83% L-threonine overproduction compared to the wild-type
strain.
Proof-of-concept studies exist for using Cyanobacteria as
producers of biofuels (Lindberg et al. 2010; Oliver et al.
2013; Nozzi et al. 2013) or bioactive compounds (Singh
et al. 2005; Essack et al. 2014; Singh et al. 2016; Humisto
et al. 2016). However, the currently available engineered
strains are not producing sufficient amounts of free fatty acids
(FFA) to be commercially viable. Attempts have been made to
commercialize ethanol production from Cyanobacteria, and
some of these technologies have been patented by Algenol
Biofuels and Joule Unlimited, reviewed by Dexter et al.
(2015). The main challenge in this process has been the dilute
rate of ethanol production, hampering the economic competi-
tiveness of the process. Despite these difficulties, the US
Environmental Protection Agency has approved a renewable
fuel pathway developed by Joule Unlimited, allowing the com-
pany to commercialize biofuels using its Cyanobactyeria-
derived ethanol (Voegele 2016).
In order to guide further improvement strategies, we
exploited the availability of over 120 cyanobacterial genomes
sequenced to-date, to establish a computational pipeline for
evaluating their natural potential to produce and secrete FFA.
Thus, we have developed an FFA SCreen (FFASC) tool, to
evaluate potential for FFA production and secretion by
cyanobacterial strains based on their theoretical proteomes
(Motwalli et al. 2017). Our results strongly suggest that the
top-ranked cyanobacterial strains that should be targeted for
this purpose primarily include Prochlorococcus (order
Prochlora les) and marine Synechococcus (order
Chroococcales). Another interesting application of
Cyanobacteria as cell factories is in the production of metab-
olites that are toxic to both terrestrial and aquatic invertebrates,
and could serve as potential pesticides (Essack et al. 2014).
Cyanobacterial genera we identified in this process as poten-
tial producers of pesticides include Lyngbya, Leptolyngbya,
Phormidium, Nostoc, Microcystis, and Planktothrix. It is in-
teresting to note that among the Cyanobacteria with top rank-
ing as FFA producers, there are some nonphotosynthetic or-
ganisms. The cyanobacterial endosymbiont of Epithemia
turgida, isolate EtSB Lake Yunoko (Nayakama et al. 2014)
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ranked at position 1, and Candidatus Atelocyanobacterium
thalassa (isolate ALOHA) (Tripp et al. 2010) ranked at posi-
tion 7. Both these strains do not have the necessary machinery
to conduct photosynthesis due to some form of evolutionary
metabolic streamlining. This streamlining could possibly have
enhanced their ability to produce FFA, in a manner similar to
reported genome reduction outcomes (Pósfai et al. 2006;
Baumgart et al. 2013; Morimoto et al. 2008). Both these
strains are symbionts of photosynthetic diatoms and algal
strains that are generally known to produce FFA (Sharma
et al. 2012). Potentially, these two organisms open different
venues for engineering Cyanobacteria for FFA production,
through a symbiotic combination of microorganisms. To re-
sume, local Cyanobacteria have the potential to secure feed-
stock for bio-based production, and their metabolic makeup is
especially suited for production of FFA, and possibly other
types of biofuels. The response of different species of
Cyanobacteria to high irradiation varies (Dillon et al. 2003),
but there are production strains, such as Synechococcus sp.,
which are highly tolerant to high irradiation at atmospheric
levels of CO2 (Bernstein et al. 2016). One of the major chal-
lenges in developing Cyanobacteria-based, non-sterilized out-
door cultivations will be possible contaminations with other
microorganisms living in the Red Sea (Raitsos et al. 2013).
Strategies have been developed to eliminate specific contam-
inants of cyanobacterial outdoor cultivations, such as the
bicarbonate-based pH-rising strategy (Zhu et al. 2017).
Along these lines, specific solutions will have to be developed
to handle the local contaminants.
While they represent a very promising venue, Cyanobacteria
are not the only possible route. High levels of sun radiation in
the region could also be used to power solar panels to generate
reducing power on large cathodic surfaces (Lovley and Nevin
2013). Solar energy could thus be used to power the production
of various carbon compounds in non-photosynthetic bacteria
(Liu et al. 2015; Sakimoto et al. 2016), thereby expanding the
range of available cell factories.
Conclusions and perspectives
We have argued that the rapid expansion of bio-based produc-
tion of fuels and chemicals bymicrobial cell factories is driven
by the three major factors: (i) the versatility of microbes that
can produce new molecules with improved properties com-
pared with currently available ones, (ii) the ability to produce
fuels and chemicals cheaper than the traditional chemical syn-
thesis, and (iii) the opportunity to produce chemicals with a
reduced environmental footprint. The Red Sea organisms,
adapted for survival in a unique environmental niche, can be
successfully exploited along all three of these axes. We have
discussed the available results from the ongoing studies that
clearly indicate that the bioprospecting in the Red Sea can
deliver significant advances in terms of versatility of produced
compounds. The tolerance of high salinity and the ability to
perform photosynthesis in this highly irradiated area also pro-
vide a solid basis for reducing the cost of fermentation and the
environmental footprint, be bypassing the need for an addi-
tional source of carbon, desalination or sterilization. The fu-
ture progress should obviously focus on extensive marine
bioprospecting based on metagenomics approaches (Kodzius
and Gojobori 2015). Sample heterogeneity is a major issue
when dealing with environmental omics, and single cell tech-
niques for reducing sample heterogeneity are arguably the best
way forward (Kodzius and Gojobori 2016). These experimen-
tal approaches should be followed by comprehensive in silico
comparison of metabolic features of local species compared to
their counterparts from other environments. This should be
used to pin-point distinguishing features that could ear-mark
new species for development of cell factories, or simply as
Bdonors^ of new pathways for metabolic engineering of
existing cell factories. Efficient in silico tools for prioritizing
among many available candidates species in the natural iso-
lates are of paramount importance in driving this process.
Finally, developing genetic tools for engineering the local
species will be the final requirement on the way to establishing
a competitive bio-based production in the region.
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